BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2000
View Archived Issues
Pharmos presents positive results from head trauma trial
Read More
MorphoSys and ImmunoGen begin human antibodies alliance
Read More
Alza to acquire Crescendo
Read More
Coulter obtains rights to technology related to RA treatment
Read More
Novo Nordisk's liquid Norditropin now available in U.S.
Read More
FDA approves breath-activated device with corticosteroid for asthma
Read More
Health Canada allows extension of paclitaxel trial for MS
Read More
IND filed by Endovasc for Liprostin
Read More
Preclinical studies indicate potential for ISAtx-247 in diabetes treatment
Read More
Pain Therapeutics reports promising phase II clinical trial results for new pain treatment
Read More
Oncolytic compound shows promise as cytomegalovirus therapy
Read More
Novel neuregulin polypeptide which promotes neuronal survival or growth
Read More
Antimalarial antibodies designed at EntreMed
Read More
Vascular-damaging combretastatin derivatives and their use in treating tumors
Read More
Synthesis and activity of phenyl pyrrolidinone glutamate antagonists described by Eisai
Read More
More potential GH secretagogues patented by Lilly
Read More
Lilly describes new series acting on the serotonergic system
Read More
Cathepsin inhibitors claimed by AstraZeneca for use in COPD
Read More
SB presents cathepsin K inhibitors and their use
Read More
New cyclic amide compounds synthesized at Japanese lab act as selective M3 antagonists
Read More
Intranasal IM-862 enters phase III
Read More
First prescription drug to treat unwanted facial hair introduced in U.S.
Read More
New antiretroviral treatment option available from Abbott
Read More
New inhibitor of cathepsin K and bone resorption reduces bone turnover in primate model
Read More
Ciba Vision and QLT seek to expand Visudyne indication in the E.U.
Read More
Beneficial effects of Ro-26-9228 on bone coupled with minimal effects on Ca homeostasis
Read More
Dual MMP/TACE inhibitor provides significant neuroprotection in bacterial meningitis
Read More
Final analysis of ISIS-2302 sparks reinitiation of development
Read More
New azasordarins characterized in several ICAAC presentations
Read More
